Apraglutide is a synthetic GLP-2 (glucagon-like peptide-2) analogue. In the trial records provided, it is being investigated for its effects on intestinal function in adults with Short Bowel Syndrome associated with Intestinal Failure (SBS-IF), and has also been studied in the context of acute Graft Versus Host Disease (aGVHD).
Investigational. Phase 3 trials are active or recruiting for SBS-IF; a Phase 2 proof-of-concept trial in aGVHD was terminated. Not FDA-approved.
Last reviewed October 13, 2026
The calculator takes vial mass, BAC water volume and your target dose, and returns the exact draw on a U-40, U-50 or U-100 insulin syringe. It does the arithmetic; it does not suggest what the dose should be.
Open the reconstitution calculator →